As we move into the final quarter of the year, experts are predicting that HedgeUp (HDUP) will surpass both Optimism (OP) and Injective (INJ) in terms of market share, user base, and total transaction volume by the end of 2023. This move would be a huge boon for HedgeUp (HDUP), as the platform has seen notable success since it is still in presale.
Why Optimism (OP) Won’t Be Able To Keep Up
Optimism (OP) is a popular L2 scalability solution that uses Optimistic Rollups (ORs). The technology is powerful, but it comes with its own set of drawbacks. The main issue is that Optimism (OP) is limited in that it can only handle one blockchain transaction at a time. This means that it may not be able to keep up with the high volume of transactions that HedgeUp (HDUP) can handle.
Optimism (OP) also serves no benefit for non-developers. Sure, Optimism (OP) may help with the overall processes of blockchain development, but most users will not benefit from the technology. With HedgeUp (HDUP) on the other hand, developers and non-developers alike can benefit, as the platform offers easy-to-use tools for investing in alternative assets.
Optimism (OP) also faces competition from other L2s. Optimism (OP) is also not as important as Ethereum has now upgraded to ETH 2.0, which is expected to bring better scalability solutions itself. So, Optimism (OP) is an interesting project but will likely be replaced by more efficient solutions soon.
Why Injective (INJ) Won’t Be Able To Compete In Q4
Injective (INJ) is a decentralized derivatives exchange that focuses on providing users with access to advanced financial derivatives. Injective (INJ) has a bunch of apps like sports prediction markets. This means that Injective (INJ) is versatile, but it does not offer the same features and services as HedgeUp (HDUP).
Injective (INJ) is mainly focused on institutional-grade trading and financial instruments whereas HedgeUp (HDUP) is for retail traders and commercial clients. This means that Injective (INJ) simply does not have the same demand. Injective (INJ) also competes with various other competitors in the derivatives exchange space. This means that although Injective (INJ) may be a legit competitor, it is not likely to make a big splash in the Q4 of 2023.
How HedgeUp (HDUP) Will Take Market Share In Q4 of 2023
By unlocking the ability to trade alternative assets safely and securely, HedgeUp (HDUP) is set to take the lion’s share of market share in Q4 of 2023.
HedgeUp (HDUP) offers users a secure and compliant platform to invest in alternative assets through NFTs. Over 80 million tokens have already been sold. And for a limited time, early investors can receive an additional 30% bonus when they purchase tokens.
This means that HedgeUp (HDUP) will have a huge advantage over both Optimism (OP) and Injective (INJ), as it is the only platform that allows for secure and compliant trading of alternative assets. Feel free to visit the links below to learn more!
Find out more about the HedgeUp (HDUP) presale here:
- Website: https://hedgeup.io/
- Presale: https://app.hedgeup.io/sign-up
- Telegram: https://t.me/HedgeUpChat
- Twitter: https://twitter.com/HedgeUpOfficial